pmid	doi	title	Hugo_Symbol
35982972	10.3389/fonc.2022.835965	Retinoblastoma in Adults: Clinical Features, Gene Mutations and Treatment Outcomes: <i>A Study of Six Cases</i>.	RB1
35896160	10.1111/1759-7714.14592	Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.	RB1
35609408	10.1016/j.lungcan.2022.05.002	Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon.	RB1
34729013	10.2147/OTT.S323700	<i>ALK</i> Rearrangement in Small-Cell Lung Cancer and Durable Response to Alectinib: A Case Report.	RB1
34657128	10.1038/s41375-021-01448-2	Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.	RB1
34551361	10.1016/j.jep.2021.114656	Chinese patent medicine Aidi injection for cancer care: An overview of systematic reviews and meta-analyses.	RB1
34440292	10.3390/genes12081118	T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.	RB1
34371436	10.1016/j.leukres.2021.106683	Proposal and clinical application of molecular genetic risk scoring system, ""MRplus"", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.	RB1
34340673	10.1186/s12885-021-08635-5	Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.	RB1
34232939	10.1097/CAD.0000000000001094	Coexistence of a secondary STRN-ALK, EML4-ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report.	RB1
34226971	10.1007/s00428-021-03148-9	Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.	RB1
33563892	10.1038/s41392-020-00412-3	Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.	RB1
33541390	10.1186/s13039-020-00526-x	Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?	RB1
33369444	10.31557/APJCP.2020.21.12.3493	Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.	RB1
33324635	10.3389/fcell.2020.577784	Dissection of Anti-tumor Activity of Histone Deacetylase Inhibitor SAHA in Nasopharyngeal Carcinoma Cells <i>via</i> Quantitative Phosphoproteomics.	RB1
33020271	10.1073/pnas.2007946117	Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.	RB1
32908255	10.1038/s41379-020-00669-7	The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma.	RB1
32661308	10.1038/s41598-020-68311-9	MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.	RB1
32592278	10.1002/gcc.22882	Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.	RB1
32345961	10.1038/s41408-020-0310-9	DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma.	RB1
32245383	10.1186/s12920-020-0709-y	Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.	RB1
31992242	10.1186/s12887-020-1923-7	Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.	RB1
31931161	10.1016/j.jep.2019.112536	Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats.	RB1
31885322	10.1080/15384101.2019.1706903	The double dealing of cyclin D1.	RB1
31411343	10.1002/path.5333	Genomic characterisation of breast fibroepithelial lesions in an international cohort.	RB1
31228652	10.1016/j.leukres.2019.05.009	Prognostic gene alterations and clonal changes in childhood B-ALL.	RB1
31202078	10.1016/j.leukres.2019.05.013	Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients.	RB1
31112375	10.1111/ijlh.13052	Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.	RB1
30988756	10.3892/etm.2019.7330	Ginsenoside Rb1 protects cardiomyocytes from oxygen-glucose deprivation injuries by targeting microRNA-21.	RB1
30938769	10.1093/labmed/lmz008	BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.	RB1
30926971	10.1038/s41588-019-0375-1	Genomic subtyping and therapeutic targeting of acute erythroleukemia.	RB1
30874617	10.1038/s41598-019-41078-4	Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.	RB1
30563911	10.1101/gr.241141.118	Human papillomavirus and the landscape of secondary genetic alterations in oral cancers.	RB1
30538135	10.1182/blood-2018-07-862151	<i>CCND2</i> and <i>CCND3</i> hijack immunoglobulin light-chain enhancers in cyclin D1<sup>-</sup> mantle cell lymphoma.	RB1
30518749	10.1038/s41419-018-1212-7	Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.	RB1
30203896	10.1002/gcc.22664	Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases.	RB1
30154667	10.2147/OTT.S172124	<i>ALK</i>-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature.	RB1
29636869		Ginsenoside Rb1 inhibit apoptosis in rat model of Alzheimer's disease induced by Aβ<sub>1-40</sub>.	RB1
29575541	10.1111/ijlh.12805	Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.	RB1
29498923	10.1200/JCO.2017.74.3617	IKZF1<sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.	RB1
29407587	10.1016/j.leukres.2018.01.012	High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.	RB1
29270859	10.1007/s12105-017-0876-0	Sinonasal Leiomyosarcoma: Clinicopathological Analysis of Nine Cases with Emphasis on Common Association with Other Malignancies and Late Distant Metastasis.	RB1
28886309	10.14715/cmb/2017.63.8.4	The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.	RB1
28674118	10.1158/1078-0432.CCR-17-0652	Retinoblastoma and Neuroblastoma Predisposition and Surveillance.	RB1
28631637	10.4103/IJPM.IJPM_466_16	An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia.	RB1
28439887	10.1111/bjh.14721	Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.	RB1
28418845	10.18632/oncotarget.16216	Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors.	RB1
28401483	10.1007/s12032-017-0940-3	Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.	RB1
28285684	10.1016/j.lungcan.2017.02.005	Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?	RB1
28281554	10.1038/modpathol.2017.3	Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.	RB1
28202519	10.1158/0008-5472.CAN-16-2571	Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia.	RB1
28126143	10.1016/j.medcli.2016.07.035	[Copy number alterations in adult patients with mature B acute lymphoblastic leukemia treated with specific immunochemotherapy].	RB1
28089441	10.1016/j.clml.2016.12.001	Prognostic Implications of Monosomies in Patients With Multiple Myeloma.	RB1
27979924	10.3324/haematol.2016.153023	Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.	RB1
27960642	10.1080/08880018.2016.1251518	The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia.	RB1
27889452	10.1016/j.molcel.2016.10.021	An RB-EZH2 Complex Mediates Silencing of Repetitive DNA Sequences.	RB1
27835869	10.18632/oncotarget.13181	OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations.	RB1
27036041	10.18632/oncotarget.8414	miR-590 promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia by inhibiting RB1.	RB1
27652204	10.21037/tlcr.2016.07.10	Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors.	RB1
27399693	10.3390/ijms17071092	miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.	RB1
27339065	10.1080/10428194.2016.1193855	Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia.	RB1
27235019	10.1016/j.jep.2016.05.055	The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.	RB1
27181063	10.1016/j.exphem.2016.04.011	Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.	RB1
26781410		[Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification].	RB1
26740820	10.1186/s13039-015-0212-x	Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).	RB1
26709271	10.3343/alm.2016.36.2.185	B-cell Acute Lymphoblastic Leukemia With t(9;22)(q34;q11) Translocation and Clonal Divergence Through ider(22) Chromosome and t(13;17)(q14;q25) Translocation.	RB1
26551667	10.1038/ng.3442	The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.	RB1
26297264	10.1016/j.clml.2015.02.035	Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia.	RB1
26280220	10.1038/labinvest.2015.104	Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.	RB1
26277549	10.1016/j.cancergen.2015.06.003	Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children.	RB1
26205622	10.1111/bjh.13613	Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.	RB1
26027540	10.1016/j.clml.2015.03.018	Genomic and Clinicopathologic Features of Primary Myelofibrosis With Isolated 13q Deletion.	RB1
26022239	10.1182/blood-2015-02-628792	High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.	RB1
25706938	10.1002/gcc.22246	A population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patients.	RB1
25676421	10.1038/leu.2015.41	Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.	RB1
25261097	10.3324/haematol.2014.112912	Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.	RB1
25126481	10.1089/biores.2014.0011	Establishment and characterization of a singaporean chinese lung adenocarcinoma cell line with four copies of the epidermal growth factor receptor gene.	RB1
24913233	10.1084/jem.20132120	Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.	RB1
24828667	10.1097/JTO.0000000000000142	Small-cell lung cancers in patients who never smoked cigarettes.	RB1
24682267	10.1182/blood-2013-07-517177	The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.	RB1
24678689	10.5858/arpa.2013-0101-RS	Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.	RB1
24633422	10.1007/s00268-014-2485-3	Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.	RB1
24189068	10.1074/jbc.M113.510669	Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.	RB1
24166298	10.1038/leu.2013.317	An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.	RB1
23989127	10.1159/000351058	Radiation therapy: retinal tumors.	RB1
23961875	10.1111/bjh.12515	Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.	RB1
23950931	10.1371/journal.pone.0070422	RNAi mediated Tiam1 gene knockdown inhibits invasion of retinoblastoma.	RB1
23900870	10.5114/pjp.2013.36199	Allelic loss of selected tumor suppressor genes in acute lymphoblastic leukemia in children.	RB1
23676220	10.4161/cc.24928	Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1.	RB1
23508010	10.3324/haematol.2013.085175	Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.	RB1
23483089	10.3343/alm.2013.33.2.130	A rare case of transformation of childhood myelodysplastic syndrome to acute lymphoblastic leukemia.	RB1
23334668	10.1038/ng.2532	The genomic landscape of hypodiploid acute lymphoblastic leukemia.	RB1
22851563	10.1200/JCO.2011.40.3907	IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.	RB1
22834783	10.3109/09273948.2012.702843	Genetics of primary intraocular tumors.	RB1
22812491	10.3109/10428194.2012.713481	Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.	RB1
22072402	10.1002/gcc.20944	High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.	RB1
21900200	10.1182/blood-2011-03-337501	Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.	RB1
21693768	10.1093/annonc/mdr289	Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion.	RB1
21527530	10.1182/blood-2011-01-329961	Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.	RB1
20435884	10.1182/blood-2009-10-247122	Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.	RB1
20435627	10.3324/haematol.2009.011114	Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.	RB1
20193845	10.1016/j.cancergencyto.2009.11.018	Array comparative genomic hybridization analysis of adult acute leukemia patients.	RB1
19594747	10.1111/j.1365-2141.2009.07791.x	Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.	RB1
19389505	10.1016/j.cancergencyto.2009.01.002	High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.	RB1
19387079	10.1167/iovs.09-3517	Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.	RB1
19083825	10.1016/j.fsigen.2008.02.008	Comparison of five DNA quantification methods.	RB1
18984860	10.1182/blood-2008-07-170183	Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling.	RB1
18832135	10.1182/blood-2008-04-153031	Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.	RB1
18694959	10.1128/MCB.00923-08	Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.	RB1
18539616	10.1093/annonc/mdn374	Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.	RB1
18458336	10.1073/pnas.0800408105	Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease.	RB1
18410453	10.1111/j.1365-2141.2008.07124.x	Advances in the understanding of mantle cell lymphoma.	RB1
18391076	10.1182/blood-2007-10-118794	Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.	RB1
17900658	10.1016/j.humpath.2007.05.009	Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.	RB1
17724719	10.1002/ijc.23038	Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes.	RB1
17563396	10.1200/JCO.2006.08.7999	Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.	RB1
17443227	10.1038/sj.leu.2404691	High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.	RB1
17332242	10.1182/blood-2006-11-057208	Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis.	RB1
16858686	10.1002/ijc.22124	Epigenetic silencing of multiple genes in primary CNS lymphoma.	RB1
16809940	10.1159/000094322	Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas.	RB1
16614728	10.1038/sj.jid.5700224	Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.	RB1
15832092	10.1097/01.pas.0000155163.40668.e7	Genetic aberrations in primary cutaneous large B-cell lymphoma: a fluorescence in situ hybridization study of 25 cases.	RB1
15572583	10.1182/blood-2004-09-3701	Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.	RB1
15315804	10.1016/j.ejca.2004.06.007	Understanding cancer at the chromosome level: 40 years of progress.	RB1
15172754	10.1016/j.cancergencyto.2003.09.022	Aberrations involving 13q12 approximately q14 are frequent secondary events in childhood acute lymphoblastic leukemia.	RB1
15061196	10.1080/1042819031000151112	Altered apoptosis pathways in mantle cell lymphoma.	RB1
15034294	10.4161/cbt.3.5.838	Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo.	RB1
12925224	10.1046/j.1523-1747.2003.12406.x	Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.	RB1
12874790	10.1002/gcc.10234	Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas.	RB1
12812137		Molecular control of the cell cycle in cancer: biological and clinical aspects.	RB1
12759925	10.1002/gcc.10200	Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.	RB1
12660028	10.1016/s0165-4608(02)00799-9	CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients.	RB1
12647795	10.14670/HH-18.449	Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferation and apoptosis in diffuse large B-cell lymphomas.	RB1
12145697	10.1038/sj.leu.2402644	Proliferation-dependent expression and phosphorylation of pRB in B cell non-Hodgkin's lymphomas: dependence on RB1 copy number.	RB1
12036888	10.1182/blood.v99.12.4554	Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.	RB1
12010815	10.1182/blood.v99.11.4116	Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia.	RB1
11706071	10.1038/modpathol.3880444	Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.	RB1
11522621		Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.	RB1
11347338		Cytogenetic abnormalities in chronic lymphocytic leukemia.	RB1
11237059	10.1038/sj.leu.2402052	Deletion of chromosomal region 13q14.3 in childhood acute lymphoblastic leukemia.	RB1
10938405	10.3892/ijo.17.3.603	Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.	RB1
10862046	10.1002/1098-2264(200008)28:4&lt;380::aid-gcc3&gt;3.0.co;2-4	Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entities.	RB1
10810367		Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates.	RB1
10803523	10.1038/sj.leu.2401761	Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.	RB1
10784395	10.3109/10428190009148398	Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and P53 monoallelic gene deletions in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization (FISH): relation to disease status.	RB1
10773403	10.1016/s0304-3835(99)00447-4	Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas.	RB1
10745626		Delineation of the frequently deleted region on chromosome arm 13q in B-cell non-Hodgkin's lymphoma.	RB1
10502318	10.1002/(sici)1098-2264(199911)26:3&lt;210::aid-gcc4&gt;3.0.co;2-j	A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t-cell lymphomas?	RB1
10379868	10.1002/(sici)1098-2264(199907)25:3&lt;222::aid-gcc4&gt;3.0.co;2-c	Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia.	RB1
10374885	10.1038/sj.leu.2401395	Frequent chromosome arm 13q deletion in aggressive non-Hodgkin's lymphoma.	RB1
10086736	10.1038/sj.leu.2401315	Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma.	RB1
10049044	10.1038/sj.leu.2401208	Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization.	RB1
9583687	10.1038/sj.onc.1201764	Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.	RB1
9563492		Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14.	RB1
9546285	10.1111/j.1750-3639.1998.tb00152.x	Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.	RB1
9130611	10.3109/10428199709042493	Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.	RB1
8724537	10.3109/10428199609051737	Allele imbalance at tumour suppressor loci during the indolent phase of follicle centre cell lymphoma.	RB1
8611453	10.1046/j.1365-2141.1996.456994.x	Microsatellite instability in follicle centre cell lymphoma.	RB1
8647524		Cell cycle regulation and human leukemias: the role of p16INK4 gene inactivation in the development of human acute lymphoblastic leukemia.	RB1
7655020		13q deletions in lymphoid malignancies.	RB1
7785662	10.1093/ajcp/103.6.748	Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.	RB1
7507704	10.1002/gcc.2870090113	Multiple genetic events involving RB1 gene deletion and amplification of chromosome 21 in a case of acute lymphocytic leukemia.	RB1
8391274	10.1001/archotol.1993.01880190031006	Genetics of tumors of the head and neck.	RB1
8380252		Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.	RB1
1886710		Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells.	RB1
1884351	10.1016/0165-4608(91)90207-b	Hemizygous deletion of the 3' end of the RB1 gene in a case of Philadelphia positive-acute lymphoblastic leukemia.	RB1
2397469	10.1016/0165-4608(90)90159-8	Structural alterations at the putative retinoblastoma locus in some human leukemias and preleukemia.	RB1
185057	10.1002/eji.1830050402	Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.	RB1
28674118	10.1158/1078-0432.CCR-17-0652	Retinoblastoma and Neuroblastoma Predisposition and Surveillance.	RB1
25550786		Epstein-Barr virus infection is inversely correlated with the expression of retinoblastoma protein in Reed-Sternberg cells in classic Hodgkin lymphoma.	RB1
20157766	10.1007/s11010-010-0394-9	Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein.	RB1
17332242	10.1182/blood-2006-11-057208	Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis.	RB1
15161658	10.1016/S0002-9440(10)63782-0	Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma.	RB1
12145697	10.1038/sj.leu.2402644	Proliferation-dependent expression and phosphorylation of pRB in B cell non-Hodgkin's lymphomas: dependence on RB1 copy number.	RB1
27377594	10.1002/mc.22523	Rb silencing mediated by the down-regulation of MeCP2 is involved in cell transformation induced by long-term exposure to hydroquinone.	RB1
27036041	10.18632/oncotarget.8414	miR-590 promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia by inhibiting RB1.	RB1
24913233	10.1084/jem.20132120	Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.	RB1
23900870	10.5114/pjp.2013.36199	Allelic loss of selected tumor suppressor genes in acute lymphoblastic leukemia in children.	RB1
18694959	10.1128/MCB.00923-08	Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.	RB1
17428253	10.1111/j.1349-7006.2007.00482.x	Telomere dysfunction and inactivation of the p16(INK4a)/Rb pathway in pyothorax-associated lymphoma.	RB1
16614728	10.1038/sj.jid.5700224	Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.	RB1
16352731	10.1073/pnas.0503886102	Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.	RB1
9395244	10.1038/sj.onc.1201431	Phosphorylated retinoblastoma protein stimulates DNA polymerase alpha.	RB1
8552662	10.1073/pnas.93.1.465	Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6.	RB1
33563892	10.1038/s41392-020-00412-3	Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.	RB1
17900658	10.1016/j.humpath.2007.05.009	Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.	RB1
17695524		Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.	RB1
10197586		The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins.	RB1
25675863	10.1016/j.leukres.2015.01.008	The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.	RB1
15878620	10.1016/j.leukres.2005.04.006	Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemia.	RB1
21518927	10.1182/blood-2010-08-301135	The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.	RB1
17287852	10.1038/sj.leu.2404583	Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.	RB1
24189068	10.1074/jbc.M113.510669	Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.	RB1
20435627	10.3324/haematol.2009.011114	Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.	RB1
15695403		Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma.	RB1
19594747	10.1111/j.1365-2141.2009.07791.x	Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.	RB1
12036888	10.1182/blood.v99.12.4554	Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.	RB1
23022380	10.1016/j.molcel.2012.08.022	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	RB1
